An Immunohistochemical Signature Comprising PTEN, MYC, and Ki67 Predicts Progression in Prostate Cancer Patients Receiving Adjuvant Docetaxel After Prostatectomy

BACKGROUND: Loss of the tumor suppressor PTEN is common in prostate cancer and may have prognostic significance. The authors examined PTEN and additional protein markers in primary tumors from patients with high-risk, localized prostate cancer who received adjuvant docetaxel in a prospective multice...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Antonarakis, Emmanuel S., Keizman, Daniel, Zhang, Zhe, Gurel, Bora, Lotan, Tamara L., Hicks, Jessica L., Fedor, Helen L., Carducci, Michael A., De Marzo, Angelo M., Eisenberger, Mario A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3572534/
https://ncbi.nlm.nih.gov/pubmed/22674438
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.27689
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados